Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, has reached an agreement with Element Materials Technology ("Element") to acquire its Life Sciences ...

Eurofins Viracor announces the availability of three plasma-based cytokine and chemokine assays — CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and Interleukin-18 (IL-18) (Test Code 33611) ...

Eurofins is Testing for Life. The Eurofins Scientific SE network of independent companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Outlook and financial objectives Comments from the CEO, Dr. Gilles Martin: “The results of the first half of 2022 ...

Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...

Oct 22 (Reuters) - French laboratory testing company Eurofins Scientific (EUFI.PA), opens new tab said on Tuesday an independent audit by Ernst & Young Paris had found no material misstatements in its ...

Thanks in part to an investment from Canada’s Strategic Innovation Fund (SIF), Eurofins CDMO is building a new biologics manufacturing facility at its site in Mississauga, Ontario, just outside of ...

Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces the signing of an agreement to divest its Electrical & Electronic Testing business (“MET Labs”) to UL Solutions Inc ...

Eurofins ERF0.43%increase; up pointing triangle Scientific shares jumped after the laboratory testing group agreed to sell its electrical and electronics testing division, MET Labs, to Illinois-based ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in French diagnostic and testing group Eurofins tumbled as much as 23 per cent on Monday after hedge ...

Eurofins offers a stable, defensive growth profile with global scale in laboratory testing across healthcare, food, and biopharma segments. Organic growth has normalized post-COVID, with management ...